Literature DB >> 9120816

Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.

J Pitha1, A Gerloczy, A Olivi.   

Abstract

Hydroxypropyl cyclodextrins are nontoxic carbohydrate derivatives of moderate molecular weight (1030-1750 Da) which form water-soluble complexes with many lipophiles. The fate of hydroxypropyl beta-cyclodextrin alone and in complex with testosterone or cholesterol injected intravenously or intracerebrally into rats was followed. More than 90% of intravenously administered hydroxypropyl beta-cyclodextrin was cleared into urine in 4 h, as previously described (Monbaliu, J.; Van Beijsterveld, L.; Meuldermans, W.; Szathmary, S.; Haykants, J. Abstracts, 5th International Symposium on Cyclodextrins, Paris, 1990; Abstract 65). After the injection of steroids in complex with hydroxypropyl beta-cyclodextrin into the tail vein of rats, the steroid component was released from the complex, before it reached the kidneys; the release occurred mainly into the proteins and lipoproteins of serum. Hydroxypropyl beta-cyclodextrins injected alone into the brain were cleared within less than 24 h, presumably via the flow of interstitial and cerebrospinal fluids, and eventually were excreted in urine. Testosterone, incorporated in a hydroxypropyl beta-cyclodextrin complex, after intracerebral injection was cleared from the brain even more rapidly than hydroxypropyl beta-cyclodextrin, presumably by crossing the blood-brain barrier and later removal to the liver by the specific carrier proteins in serum. Complexed cholesterol, in a similar experiment, was largely retained in the brain and its distribution there was uneven and remained that way for at least 3 days. It is clear that lipophilic agents, after their incorporation into hydroxypropyl beta-cyclodextrin complexes and subsequent in vivo administration, are rapidly released and exchanged into the plasma. In absence of plasma they enter tissues surrounding the injection site and thus are also promptly transferred into the organism's lipid systems. The manner in which different lipophilic agents are transported in vivo appears not to be greatly affected by their previous complexation; rather hydroxypropyl cyclodextrins just enable their entry in a larger amount and in an exchangeable, nonaggregated form.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9120816     DOI: 10.1002/jps.2600830615

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream.

Authors:  Anna M Taylor; Bing Liu; Yelenis Mari; Benny Liu; Joyce J Repa
Journal:  J Lipid Res       Date:  2012-08-14       Impact factor: 5.922

2.  2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease.

Authors:  Sarah Ward; Patricia O'Donnell; Steven Fernandez; Charles H Vite
Journal:  Pediatr Res       Date:  2010-07       Impact factor: 3.756

3.  Effects of the increase in neuronal fatty acids availability on food intake and satiety in mice.

Authors:  Roberto Coccurello; Antonio Caprioli; Sara Bellantuono; Francesca R D'Amato; Roberto Conti; Fabio Giannessi; Franco Borsini; Anna Moles
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

4.  Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1⁻/⁻ mice.

Authors:  Akshay Muralidhar; Ivan A Borbon; Dyadin M Esharif; Wangjing Ke; Rinu Manacheril; Michael Daines; Robert P Erickson
Journal:  Mol Genet Metab       Date:  2011-03-05       Impact factor: 4.797

5.  Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease.

Authors:  Charles H Vite; Jessica H Bagel; Gary P Swain; Maria Prociuk; Tracey U Sikora; Veronika M Stein; Patricia O'Donnell; Therese Ruane; Sarah Ward; Alexandra Crooks; Su Li; Elizabeth Mauldin; Susan Stellar; Marc De Meulder; Mark L Kao; Daniel S Ory; Cristin Davidson; Marie T Vanier; Steven U Walkley
Journal:  Sci Transl Med       Date:  2015-02-25       Impact factor: 17.956

6.  Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid.

Authors:  Benny Liu; Charina M Ramirez; Anna M Miller; Joyce J Repa; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-11-18       Impact factor: 5.922

7.  Pharmacokinetics and distribution of 2-hydroxypropyl-β-cyclodextrin following a single intrathecal dose to cats.

Authors:  Mark L Kao; Susan Stellar; Eric Solon; Alfred Lordi; Nicole Kasica; Gary Swain; Jessica H Bagel; Brittney L Gurda; Charles H Vite
Journal:  J Inherit Metab Dis       Date:  2019-12-15       Impact factor: 4.750

8.  Photodynamic therapy - hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity.

Authors:  Nikola Plenagl; Lili Duse; Benjamin Sebastian Seitz; Nathalie Goergen; Shashank Reddy Pinnapireddy; Jarmila Jedelska; Jana Brüßler; Udo Bakowsky
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 9.  Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann-Pick Disease Type C1.

Authors:  Anja U Bräuer; Angela Kuhla; Carsten Holzmann; Andreas Wree; Martin Witt
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.